Medicine guide
Ilumira
- Prescription status not stated
- Everything that fits nowhere else, such as contrast media
- Active substance
- Lutetium (177Lu) chloride
- Made by
- Shine Europe B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Ilumira is a radiopharmaceutical precursor, and it is not intended for direct use in patients. It is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177Lu) chloride.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Shine Europe B.V. |
|---|---|
| Active substance | Lutetium (177Lu) chloride |
| Used in | Everything that fits nowhere else, such as contrast media |
| Classification | V10X · Everything that fits nowhere else, such as contrast media |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Authorised on | 2026-03-26 |
| Last updated by the regulator | 2026-04-01 |
| EMA product number | EMEA/H/C/006596 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
TheralugandEU authorisation Eckert & Ziegler Radiopharma GmbH · Lutetium (177Lu) chloride · V10XEndolucinBetaEU authorisation ITM Medical Isotopes GmbH · Lutetium (177Lu) chloride · V10XLumarkEU authorisation I.D.B. Radiopharmacy B.V. · Lutetium (177Lu) chloride · V10Lutetium (177Lu) chloride Billev (previously Illuzyce)EU authorisation Billev Pharma Aps · Lutetium (177Lu) chloride · V10X